AwardedAwarded 17 October 2025
Nucleic Acid Testing (NAT) Managed Service
The Common Services Agency (more commonly known as NHS National Services Scotland) (NSS) · NHS and health
In brief
The Common Services Agency (more commonly known as NHS National Services Scotland) (NSS) awarded medical supplies work to Roche Diagnostics Ltd on 17 October 2025.
Built from the notice's own fields. Always check the official notice before you bid.
What the notice says
The Scottish National Blood Transfusion Service, Northern Ireland Blood Transfusion Service and Welsh Blood Service all require a fully integrated microbiology managed service system for NAT (Nucleic Acid Testing). This includes equipment, maintenance, consumables, spare parts, upgrades, training, clinical education material, remote diagnostics, reporting and supports all to deliver a final result to the Authority’s information management system. Mandatory assays include the ability to detect HCV RNA, HBV DNA, HIV RNA, HEV RNA, B19V DNA and HAV RNA in plasma/serum samples from blood donors and HCV RNA, HIV RNA, HBV DNA, HEV RNA, B19V DNA and HAV RNA in plasma/ serum samples from tissue and stem cell donors.
Who won
| Winner | Value | Dates |
|---|---|---|
| Roche Diagnostics Ltd 2 bids received | £7,300,000 |
Values as the award notice gives them, excluding VAT where stated.
Timeline
- Contract award notice · notice 066855-2025
About the buyer
The Common Services Agency (more commonly known as NHS National Services Scotland) (NSS)Last 12 months
Procurements
104Awards
67Suppliers it has used most for medical supplies
- B. Braun Medical Limited5 contracts
- Fresenius Kabi Limited4 contracts
- Johnson & Johnson Medical Ltd4 contracts
- Pfizer Limited4 contracts
- Roche Products Ltd4 contracts
Similar open tenders
All open medical supplies tenders- £460kframework ceiling
- Value not stated
- Value not stated
- £650kestimated
- £335mframework ceiling
From notice 066855-2025 on Find a Tender, first published 20 October 2025. We last checked for changes on 28 September 2026.